Mushroom Supplements and Immunosuppressants: Critical Safety Information for Transplant and Autoimmune Patients

This article may contain affiliate links. TopShelfMushrooms.com may earn a commission on purchases made through these links, at no additional cost to you. This does not influence our research evaluations. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Mushroom Supplements and Immunosuppressants: Critical Interaction Guide

Who This Page Is For

If you’ve had an organ transplant, are on immunosuppressive therapy for autoimmune disease, or take medications that deliberately weaken your immune system, this guide is essential before considering mushroom supplements. The interaction between immune-stimulating mushrooms and immunosuppressive medications is fundamentally at odds—understanding this conflict can protect your health and your treatment outcomes.

The Concern: Why This Interaction Matters

Medicinal mushrooms rich in beta-glucans—particularly reishi, turkey tail, and maitake—are designed to stimulate and enhance immune function. Immunosuppressive medications, by contrast, are designed to suppress or dampen immune activity. Taking an immune-stimulating mushroom while on immunosuppressants creates a direct pharmacological conflict: the mushroom works against your medication’s intended effect, potentially compromising transplant survival or autoimmune disease control.

This is not a minor concern. The National Kidney Foundation explicitly warns that some supplements can “change the levels (up or down) of immunosuppressants in the blood” and urge caution in transplant patients. For organ transplant recipients, this interaction can literally mean the difference between graft survival and graft rejection.

The Science: Beta-Glucan Immune Stimulation

Medicinal mushrooms contain beta-glucans, branched polysaccharides that activate innate immune responses through specific receptors on immune cells called Dectin-1. When beta-glucans bind to Dectin-1 (found on macrophages, dendritic cells, and neutrophils), they trigger:

• Macrophage activation and proliferation
• Increased production of pro-inflammatory cytokines (IL-6, TNF-alpha, IL-1)
• Enhanced natural killer (NK) cell activity
• Increased T-helper 1 (Th1) immune response
• Upregulation of antigen presentation to immune cells

This is beneficial for people with weak immune systems fighting infections or cancer. It is deeply problematic for people whose immune system is actively attacking their own transplanted organ or their body’s own tissues (autoimmune disease).

Which Mushroom Compounds Are Most Immunostimulating

Not all mushrooms are equally immunostimulating. Understanding the hierarchy helps identify which are highest risk:

Turkey Tail (Trametes versicolor) — Strongest Immunostimulation
Contains polysaccharide-K (PSK) and polysaccharide-peptide (PSP), both with potent beta-glucan content and robust human clinical evidence for immune activation. Turkey tail is the most immunostimulating medicinal mushroom and carries the highest interaction risk for immunosuppressed patients.

Maitake (Grifola frondosa) — Very Strong Immunostimulation
The Maitake D-fraction and beta-glucan content significantly increase proliferation, differentiation, and activation of T-helper 1 cells. In vitro research shows robust immune cell activation. High risk for immunosuppressed patients.

Reishi (Ganoderma lucidum) — Moderate-Strong Immunostimulation
Reishi is often described as an “immune modulator,” which can be misleading. While reishi does have anti-inflammatory effects, it also stimulates immune cell activity through beta-glucan mechanisms. Contains both immune-stimulating and balancing properties, but net effect is immune enhancement. Moderate-to-high risk.

Shiitake (Lentinula edodes) — Moderate Immunostimulation
Contains lentinan, a beta-glucan with immune-stimulating effects documented in human studies, particularly for cancer immunotherapy applications. Moderate risk for immunosuppressed patients.

Cordyceps (Cordyceps militaris/sinensis) — Mild-Moderate Immunostimulation
While cordyceps has some immune-enhancing properties, they are generally less potent than reishi, maitake, or turkey tail. Lower risk, but not risk-free.

Lion’s Mane (Hericium erinaceus) — Minimal Immunostimulation
Lion’s mane works primarily through nerve growth factor (NGF) effects on neurological tissue, not through beta-glucan immune activation. While lion’s mane has anti-inflammatory properties, it does not strongly stimulate immune cell proliferation. Lowest risk for immunosuppressed patients.

Specific Medications at Absolute or High Risk

TRANSPLANT IMMUNOSUPPRESSANTS — Absolute Contraindication

If you have had an organ transplant and are on post-transplant immunosuppressive therapy, mushroom supplements with immune-stimulating properties are generally contraindicated. Your transplanted organ’s survival depends on suppressing your immune system’s ability to recognize and attack the foreign tissue. An immune-stimulating supplement directly undermines this goal.

• Tacrolimus (Prograf) — Calcineurin inhibitor; immune-suppressing
• Cyclosporine (Sandimmune, Neoral) — Calcineurin inhibitor; potent immune suppression
• Mycophenolate (CellCept, Myfortic) — Inosine monophosphate dehydrogenase inhibitor; suppresses T and B cell proliferation
• Azathioprine (Imuran) — Purine analog; anti-proliferative immunosuppressant
• Everolimus (Afinitor) — mTOR inhibitor; potent immunosuppressant
• Sirolimus (Rapamune) — mTOR inhibitor; immunosuppressant

For transplant patients, the rule is simple: avoid beta-glucan-rich mushroom supplements entirely unless explicitly cleared by your transplant team. The risk of graft rejection is too high to take chances.

AUTOIMMUNE DISEASE IMMUNOSUPPRESSANTS — High Risk, Risk Assessment Required

If you take immunosuppressive therapy for autoimmune conditions (rheumatoid arthritis, lupus, inflammatory bowel disease, multiple sclerosis, etc.), mushroom supplements create a theoretical conflict:

• Prednisone/Glucocorticoids — Broad immunosuppression
• Methotrexate — Immunosuppressive and anti-inflammatory
• Sulfasalazine — Immunosuppressive for autoimmune conditions
• Leflunomide (Arava) — Pyrimidine synthesis inhibitor; immunosuppressive
• JAK Inhibitors (baricitinib, tofacitinib, upadacitinib) — Block Janus kinase signaling; potent immunosuppression

BIOLOGIC IMMUNOSUPPRESSANTS — High Risk

Biologic medications that target specific immune pathways are increasingly used for autoimmune and inflammatory conditions. These work through different mechanisms than traditional immunosuppressants, but the principle remains: immune-stimulating mushrooms oppose their therapeutic effect.

• TNF-alpha Inhibitors — adalimumab (Humira), infliximab (Remicade), etanercept (Enbrel), certolizumab (Cimzia), golimumab (Simponi)
• IL-6 Inhibitors — tocilizumab (Actemra), sarilumab (Kevzara)
• IL-1 Inhibitors — anakinra (Kineret), canakinumab (Ilaris)
• T-Cell Costimulation Blockers — abatacept (Orencia)
• B-Cell Depleting Agents — rituximab (Rituxan), belimumab (Benlysta)

Risk Stratification: Immunosuppressed Patient Assessment

Mechanism of Conflict: How Mushrooms Undermine Immunosuppressants

Direct Immune Activation vs. Immune Suppression
Immunosuppressants work by blocking T cell proliferation, reducing inflammatory cytokine production, or depleting specific immune cell populations. Beta-glucans in mushrooms activate the same immune pathways these medications suppress. The result is a pharmacological tug-of-war: the mushroom pulls immune function up while the medication pulls it down. The outcome is unpredictable and patient-dependent, but the net effect is reduced immunosuppressive efficacy.

Timing and Dosing Interactions
If a patient takes immunosuppressants on a consistent schedule designed to maintain a therapeutic level of immune suppression, adding an immune-stimulating mushroom creates fluctuating immune states: suppressed when the mushroom effect is low, less suppressed when mushroom effect is high. This variability can trigger immune system “rebound” effects or breakthrough autoimmune activity.

Graft Rejection Risk in Transplant Patients
Organ transplant recipients maintain a delicate immunological balance: enough immune suppression to prevent rejection, but not so much that opportunistic infections become life-threatening. An immune-stimulating mushroom shifts this balance toward rejection risk. Even a small increase in immune activation can be clinically significant in a transplant patient.

When to Absolutely Avoid Mushroom Supplements

Do NOT use beta-glucan-rich mushroom supplements if you meet ANY of these criteria:

• You have had an organ transplant (heart, lung, kidney, liver, pancreas, intestine) and take any post-transplant immunosuppressive medications
• You have active autoimmune disease that is currently being treated with biologics (TNF-alpha, IL-6, or IL-1 inhibitors)
• You are on JAK inhibitors for any autoimmune or inflammatory condition
• You have inflammatory bowel disease (Crohn’s or ulcerative colitis) and are on immunosuppressants
• You are being treated for multiple sclerosis with disease-modifying therapies
• Your rheumatologist has explicitly advised you not to use immune-stimulating supplements
• You are experiencing an active flare of your autoimmune condition

Mushroom Alternatives for Immunosuppressed Patients

If you want to use mushroom supplements for general wellness while immunosuppressed, these options carry minimal immune-stimulating activity:

Lion’s Mane (Hericium erinaceus)
Works primarily through nerve growth factor and neurological pathways, not immune stimulation. Research supports cognitive, neuroprotective, and mood benefits. Safe for transplant and autoimmune patients. Discuss with your healthcare provider as a precaution, but generally well-tolerated.

Cordyceps (Lower Doses)
While cordyceps has some immune properties, they are mild compared to turkey tail or maitake. At lower doses (500-750 mg daily), cordyceps is generally lower-risk. Still worth mentioning to your healthcare team, but often considered acceptable.

Oyster Mushroom
Limited research but does not appear to have strong immune-stimulating properties comparable to reishi or turkey tail. Can be consumed as culinary form safely in immunosuppressed patients.

What Transplant Patients Need to Know

Why the “No Supplements” Rule Exists
Transplant programs are conservative about supplements because the stakes are extremely high. Your transplanted organ is a finite resource—if it’s rejected, you need another transplant, which may not be available. A preventable rejection caused by an immune-stimulating supplement is viewed as an avoidable tragedy by transplant teams.

The National Kidney Foundation’s Official Position
The National Kidney Foundation warns that some supplements can change immunosuppressant levels in the blood. They recommend all transplant patients consult with their transplant team before starting ANY supplement, including mushroom-based products.

Graft Longevity Numbers
For context on why this matters: kidney transplants from living donors have a 10-year survival rate of ~80%; from deceased donors, ~60%. Heart transplants have 5-year survival rates of ~70%; lung transplants ~50%. These numbers have improved significantly, but rejection remains the #1 cause of long-term graft loss. Anything that increases rejection risk is seriously considered.

What Autoimmune Disease Patients Need to Know

Disease Flares and Immune Stimulation
Autoimmune flares can be triggered by immune activation. If you’re on immunosuppressants to keep your disease controlled, adding an immune-stimulating mushroom raises the risk of breakthrough disease activity. This might manifest as:

• Joint pain and swelling flares (rheumatoid arthritis)
• Digestive symptoms worsening (inflammatory bowel disease)
• Neurological symptoms re-emerging (multiple sclerosis)
• Rash or systemic symptoms increasing (lupus)

Medication Adjustment Complications
If you’re on biologics or JAK inhibitors, your dose is carefully calibrated to your disease activity level. Adding an immune-stimulating supplement can shift this balance, potentially requiring dose increases to regain disease control. Higher doses = increased infection risk and side effects.

When Immune Stimulation Might Seem Appealing (But Isn’t Safe)
Some autoimmune patients feel they need immune support during seasonal illness periods or around vaccination time. While this impulse is understandable, using immune-stimulating mushrooms in an autoimmune patient is risky. The better approach is discussing timing of vaccinations and seasonal immune strategies with your rheumatologist, not self-treating with supplements.

Questions to Ask Your Healthcare Team

For Transplant Recipients:

• “Are there any medicinal mushroom supplements that are safe for me to use while on my immunosuppressants?”
• “Would you like me to inform you before I start any new supplement, including mushrooms?”
• “Are there specific wellness or immune-support strategies you recommend for transplant patients?”

For Autoimmune Disease Patients:

• “Would mushroom supplements interfere with my current disease-modifying therapy?”
• “Are there any immune-supporting supplements you consider safe alongside my immunosuppressants?”
• “What should I watch for that might indicate a disease flare if I experiment with new supplements?”

The Bottom Line

Beta-glucan-rich medicinal mushrooms (reishi, turkey tail, maitake, shiitake) are immune stimulants by design. If you take immunosuppressive medications—whether post-transplant or for autoimmune disease—these mushrooms work directly against your treatment goal. For organ transplant recipients, immune-stimulating mushrooms are generally contraindicated due to graft rejection risk. For autoimmune disease patients on biologics, JAK inhibitors, or other immunosuppressants, high-immune-stimulating mushrooms should be avoided or used only with explicit medical approval and monitoring. Low-risk alternatives like lion’s mane may be options for some immunosuppressed patients, but must be discussed with your healthcare team first. Never add mushroom supplements without informing your transplant team, rheumatologist, or immunologist. The safety of your transplanted organ or disease control is worth the brief conversation with your medical team.

Medical Disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice. Organ transplant recipients and patients with autoimmune disease taking immunosuppressive medications should NOT start mushroom supplements without explicit approval from their transplant team, rheumatologist, or immunologist. Beta-glucan-rich mushrooms may stimulate immune responses that directly conflict with immunosuppressive therapy, potentially causing graft rejection or autoimmune flares. The information provided is general; individual medical situations vary significantly. Always consult your healthcare provider, transplant team, or rheumatologist before starting any supplement, including mushroom-based products. Do not discontinue immunosuppressive medications based on this article. If you experience signs of graft rejection (fever, pain at transplant site, decreased urine output) or autoimmune flare (worsening symptoms of your underlying condition), seek immediate medical attention.